Vanguard Group Inc Voyager Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,186,427 shares of VYGR stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,186,427
Previous 3,038,564 4.87%
Holding current value
$17.1 Million
Previous $24 Million 22.45%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$5.77 - $9.27 $853,169 - $1.37 Million
147,863 Added 4.87%
3,186,427 $18.6 Million
Q2 2024

Aug 13, 2024
SELL
$7.42 - $10.54 $1.43 Million - $2.04 Million
-193,134 Reduced 5.98%
3,038,564 $24 Million
Q1 2024

May 10, 2024
BUY
$7.15 - $10.84 $5.02 Million - $7.61 Million
702,030 Added 27.75%
3,231,698 $30.1 Million
Q4 2023

Feb 14, 2024
BUY
$6.28 - $8.81 $299,625 - $420,333
47,711 Added 1.92%
2,529,668 $21.4 Million
Q3 2023

Nov 14, 2023
BUY
$7.55 - $11.25 $46,289 - $68,973
6,131 Added 0.25%
2,481,957 $19.2 Million
Q2 2023

Aug 14, 2023
BUY
$6.94 - $13.99 $3.55 Million - $7.15 Million
511,146 Added 26.02%
2,475,826 $28.3 Million
Q1 2023

May 15, 2023
BUY
$6.0 - $10.78 $57,048 - $102,496
9,508 Added 0.49%
1,964,680 $15.1 Million
Q4 2022

Feb 10, 2023
BUY
$4.94 - $6.61 $288,288 - $385,746
58,358 Added 3.08%
1,955,172 $11.9 Million
Q3 2022

Nov 14, 2022
SELL
$5.57 - $7.47 $518,416 - $695,255
-93,073 Reduced 4.68%
1,896,814 $11.2 Million
Q2 2022

Aug 12, 2022
BUY
$4.82 - $10.09 $299,322 - $626,589
62,100 Added 3.22%
1,989,887 $11.8 Million
Q1 2022

May 13, 2022
SELL
$2.75 - $9.44 $396,709 - $1.36 Million
-144,258 Reduced 6.96%
1,927,787 $14.7 Million
Q4 2021

Feb 14, 2022
SELL
$2.47 - $5.55 $224,347 - $504,100
-90,829 Reduced 4.2%
2,072,045 $5.62 Million
Q3 2021

Nov 12, 2021
SELL
$2.63 - $4.12 $16,040 - $25,127
-6,099 Reduced 0.28%
2,162,874 $5.69 Million
Q2 2021

Aug 13, 2021
BUY
$3.94 - $5.44 $8.55 Million - $11.8 Million
2,168,973 New
2,168,973 $8.96 Million

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $207M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email